Logo image of CRUS

CIRRUS LOGIC INC (CRUS) Stock Fundamental Analysis

NASDAQ:CRUS - Nasdaq - US1727551004 - Common Stock - Currency: USD

100.92  +1.5 (+1.51%)

After market: 102.5 +1.58 (+1.57%)

Fundamental Rating

7

Taking everything into account, CRUS scores 7 out of 10 in our fundamental rating. CRUS was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making CRUS a very profitable company, without any liquidiy or solvency issues. CRUS is valued quite cheap, while showing a decent growth score. This is a good combination! With these ratings, CRUS could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

CRUS had positive earnings in the past year.
In the past year CRUS had a positive cash flow from operations.
Each year in the past 5 years CRUS has been profitable.
In the past 5 years CRUS always reported a positive cash flow from operatings.
CRUS Yearly Net Income VS EBIT VS OCF VS FCFCRUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

CRUS has a better Return On Assets (13.91%) than 83.33% of its industry peers.
CRUS has a Return On Equity of 17.00%. This is in the better half of the industry: CRUS outperforms 77.78% of its industry peers.
CRUS has a Return On Invested Capital of 13.56%. This is amongst the best in the industry. CRUS outperforms 83.33% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CRUS is in line with the industry average of 11.92%.
The 3 year average ROIC (13.35%) for CRUS is below the current ROIC(13.56%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.91%
ROE 17%
ROIC 13.56%
ROA(3y)12.08%
ROA(5y)11.62%
ROE(3y)15.39%
ROE(5y)14.96%
ROIC(3y)13.35%
ROIC(5y)12.11%
CRUS Yearly ROA, ROE, ROICCRUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of CRUS (17.19%) is better than 74.07% of its industry peers.
CRUS's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 20.88%, CRUS is in the better half of the industry, outperforming 78.70% of the companies in the same industry.
In the last couple of years the Operating Margin of CRUS has grown nicely.
CRUS has a better Gross Margin (51.48%) than 67.59% of its industry peers.
CRUS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.88%
PM (TTM) 17.19%
GM 51.48%
OM growth 3Y3.62%
OM growth 5Y19.01%
PM growth 3Y-1.11%
PM growth 5Y15.12%
GM growth 3Y-0.29%
GM growth 5Y0.32%
CRUS Yearly Profit, Operating, Gross MarginsCRUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRUS is destroying value.
CRUS has less shares outstanding than it did 1 year ago.
CRUS has less shares outstanding than it did 5 years ago.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRUS Yearly Shares OutstandingCRUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRUS Yearly Total Debt VS Total AssetsCRUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 9.34 indicates that CRUS is not in any danger for bankruptcy at the moment.
The Altman-Z score of CRUS (9.34) is better than 76.85% of its industry peers.
There is no outstanding debt for CRUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.34
ROIC/WACC0.94
WACC14.44%
CRUS Yearly LT Debt VS Equity VS FCFCRUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CRUS has a Current Ratio of 5.34. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
CRUS's Current ratio of 5.34 is amongst the best of the industry. CRUS outperforms 81.48% of its industry peers.
CRUS has a Quick Ratio of 4.16. This indicates that CRUS is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.16, CRUS is in the better half of the industry, outperforming 76.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.34
Quick Ratio 4.16
CRUS Yearly Current Assets VS Current LiabilitesCRUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

CRUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.53%, which is quite impressive.
CRUS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.11% yearly.
The Revenue has grown by 8.24% in the past year. This is quite good.
Measured over the past years, CRUS shows a quite strong growth in Revenue. The Revenue has been growing by 8.58% on average per year.
EPS 1Y (TTM)29.53%
EPS 3Y12.95%
EPS 5Y20.11%
EPS Q2Q%25%
Revenue 1Y (TTM)8.24%
Revenue growth 3Y9.32%
Revenue growth 5Y8.58%
Sales Q2Q%12.64%

3.2 Future

Based on estimates for the next years, CRUS will show a small growth in Earnings Per Share. The EPS will grow by 5.26% on average per year.
The Revenue is expected to grow by 5.18% on average over the next years.
EPS Next Y-0.24%
EPS Next 2Y2.49%
EPS Next 3Y5.26%
EPS Next 5YN/A
Revenue Next Year3.05%
Revenue Next 2Y3.69%
Revenue Next 3Y5.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRUS Yearly Revenue VS EstimatesCRUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CRUS Yearly EPS VS EstimatesCRUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 13.46, the valuation of CRUS can be described as correct.
90.74% of the companies in the same industry are more expensive than CRUS, based on the Price/Earnings ratio.
CRUS is valuated cheaply when we compare the Price/Earnings ratio to 28.39, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.56, CRUS is valued correctly.
Based on the Price/Forward Earnings ratio, CRUS is valued cheaper than 86.11% of the companies in the same industry.
CRUS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.37.
Industry RankSector Rank
PE 13.46
Fwd PE 14.56
CRUS Price Earnings VS Forward Price EarningsCRUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CRUS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CRUS is cheaper than 86.11% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRUS indicates a rather cheap valuation: CRUS is cheaper than 99.07% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 9.77
EV/EBITDA 10.66
CRUS Per share dataCRUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

CRUS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.67
EPS Next 2Y2.49%
EPS Next 3Y5.26%

More info and screens

0

5. Dividend

5.1 Amount

CRUS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CIRRUS LOGIC INC

NASDAQ:CRUS (1/28/2025, 5:20:00 PM)

After market: 102.5 +1.58 (+1.57%)

100.92

+1.5 (+1.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-04 2025-02-04/amc
Inst Owners93.34%
Inst Owner Change0.96%
Ins Owners0.43%
Ins Owner Change-1.19%
Market Cap5.36B
Analysts77.14
Price Target132.6 (31.39%)
Short Float %2.66%
Short Ratio1.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)43.96%
Min EPS beat(2)9.35%
Max EPS beat(2)78.58%
EPS beat(4)4
Avg EPS beat(4)54.59%
Min EPS beat(4)9.35%
Max EPS beat(4)89.62%
EPS beat(8)8
Avg EPS beat(8)39.89%
EPS beat(12)12
Avg EPS beat(12)37.08%
EPS beat(16)15
Avg EPS beat(16)30.74%
Revenue beat(2)2
Avg Revenue beat(2)8.56%
Min Revenue beat(2)2.07%
Max Revenue beat(2)15.06%
Revenue beat(4)4
Avg Revenue beat(4)11.16%
Min Revenue beat(4)2.07%
Max Revenue beat(4)15.17%
Revenue beat(8)7
Avg Revenue beat(8)7.71%
Revenue beat(12)11
Avg Revenue beat(12)8.43%
Revenue beat(16)14
Avg Revenue beat(16)6.57%
PT rev (1m)0%
PT rev (3m)-13.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-14.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.61%
Valuation
Industry RankSector Rank
PE 13.46
Fwd PE 14.56
P/S 2.81
P/FCF 9.77
P/OCF 9.25
P/B 2.78
P/tB 3.66
EV/EBITDA 10.66
EPS(TTM)7.5
EY7.43%
EPS(NY)6.93
Fwd EY6.87%
FCF(TTM)10.33
FCFY10.24%
OCF(TTM)10.91
OCFY10.81%
SpS35.88
BVpS36.28
TBVpS27.6
PEG (NY)N/A
PEG (5Y)0.67
Profitability
Industry RankSector Rank
ROA 13.91%
ROE 17%
ROCE 18.72%
ROIC 13.56%
ROICexc 17.49%
ROICexgc 24.29%
OM 20.88%
PM (TTM) 17.19%
GM 51.48%
FCFM 28.8%
ROA(3y)12.08%
ROA(5y)11.62%
ROE(3y)15.39%
ROE(5y)14.96%
ROIC(3y)13.35%
ROIC(5y)12.11%
ROICexc(3y)17.57%
ROICexc(5y)16.14%
ROICexgc(3y)27.26%
ROICexgc(5y)24.15%
ROCE(3y)18.43%
ROCE(5y)16.72%
ROICexcg growth 3Y3.78%
ROICexcg growth 5Y15.34%
ROICexc growth 3Y2.32%
ROICexc growth 5Y17.66%
OM growth 3Y3.62%
OM growth 5Y19.01%
PM growth 3Y-1.11%
PM growth 5Y15.12%
GM growth 3Y-0.29%
GM growth 5Y0.32%
F-Score7
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 61.27%
Cap/Sales 1.6%
Interest Coverage 250
Cash Conversion 129.4%
Profit Quality 167.52%
Current Ratio 5.34
Quick Ratio 4.16
Altman-Z 9.34
F-Score7
WACC14.44%
ROIC/WACC0.94
Cap/Depr(3y)59.75%
Cap/Depr(5y)50.89%
Cap/Sales(3y)1.92%
Cap/Sales(5y)1.79%
Profit Quality(3y)113.36%
Profit Quality(5y)132.62%
High Growth Momentum
Growth
EPS 1Y (TTM)29.53%
EPS 3Y12.95%
EPS 5Y20.11%
EPS Q2Q%25%
EPS Next Y-0.24%
EPS Next 2Y2.49%
EPS Next 3Y5.26%
EPS Next 5YN/A
Revenue 1Y (TTM)8.24%
Revenue growth 3Y9.32%
Revenue growth 5Y8.58%
Sales Q2Q%12.64%
Revenue Next Year3.05%
Revenue Next 2Y3.69%
Revenue Next 3Y5.18%
Revenue Next 5YN/A
EBIT growth 1Y32.38%
EBIT growth 3Y13.28%
EBIT growth 5Y29.21%
EBIT Next Year15.52%
EBIT Next 3Y24.66%
EBIT Next 5YN/A
FCF growth 1Y170.38%
FCF growth 3Y5.29%
FCF growth 5Y17.53%
OCF growth 1Y148.95%
OCF growth 3Y6.52%
OCF growth 5Y15.33%